Applied Therapeutics Inc (APLT)

12:30 PM

Press Release Distribution & PR Platform - ACCESS Newswire

12:30 PM

Apr 24, 2025

Applied Therapeutics Inc (NASDAQ:APLT)’s 12-Month Price Target Is Now Set At 5. - Marketing Sentinel

Apr 24, 2025

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 16, 2025

Apr 15, 2025

Applied Therapeutics Reports 2024 Financial Results and Leadership Changes - TipRanks

Apr 15, 2025

Apr 15, 2025

Applied Therapeutics, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Apr 15, 2025

Applied Therapeutics (APLT) Reports Lower Revenue But Reinforces Strategic Focus | APLT Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Fi - GuruFocus

Apr 15, 2025

Apr 14, 2025

Applied Therapeutics earnings beat by $0.71, revenue fell short of estimates - Investing.com Canada

Apr 14, 2025

Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - The Manila Times

Apr 14, 2025

Apr 14, 2025

Applied Therapeutics Strengthens Balance Sheet: $79.4M Cash Position Powers Drug Development Push - Stock Titan

Apr 14, 2025

Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results | APLT Stock News - GuruFocus

Apr 14, 2025

Apr 13, 2025

Norges Bank Acquires New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 13, 2025

Apr 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Apr 12, 2025

Apr 10, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 04, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - MarketScreener

Apr 04, 2025

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Applied Therapeutics, Inc. (APLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

Apr 03, 2025

Apr 02, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Charles Schwab Investment Management Inc. Has $600,000 Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 01, 2025

Mar 31, 2025

Applied Therapeutics Delays Yearly Report Filing - TipRanks

Mar 31, 2025

Mar 31, 2025

Applied Therapeutics files Form 12b-25 with SEC - TipRanks

Mar 31, 2025

Mar 31, 2025

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Applied Therapeutics Requests SEC Extension: What This Means for 2024 Financial Results - Stock Titan

Mar 31, 2025

Mar 31, 2025

146,900 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Swiss National Bank - Defense World

Mar 31, 2025

Mar 22, 2025

Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

Mar 22, 2025

Mar 22, 2025

Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Mar 22, 2025

Mar 21, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

Mar 21, 2025

Mar 21, 2025

APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Mar 21, 2025

Mar 19, 2025

Applied Therapeutics appoints new Chief Regulatory Officer By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - citybiz

Mar 19, 2025

Mar 19, 2025

APLT DEADLINE ALERT: Applied Therapeutics Investors have until February 18 before Expiration of the Class Action DeadlineContact BFA Law if You Lost Money - Louisiana First News

Mar 19, 2025

Mar 19, 2025

Applied Therapeutics Names Todd Baumgartner As Chief Regulatory Officer - Nasdaq

Mar 19, 2025

Mar 19, 2025

Applied Therapeutics appoints new Chief Regulatory Officer - Investing.com

Mar 19, 2025

Mar 19, 2025

Applied Therapeutics Strengthens Drug Approval Push With 12-Time FDA Success Veteran - Stock Titan

Mar 19, 2025

Mar 17, 2025

Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 17, 2025

Mar 16, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $6.10 - MarketBeat

Mar 16, 2025

Mar 13, 2025

Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

Mar 13, 2025

Mar 13, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 13, 2025